Yes, a baby can still get RSV after vaccination or nirsevimab; both cut the risk and tend to make illness milder.
Parents hear that there’s finally RSV protection for babies and breathe a little easier. Then comes the next worry: can a baby still get RSV after getting the new protection? Here’s the plain answer, followed by the practical steps that keep your little one safer through peak season.
Can A Baby Get RSV If Vaccinated? Real-World Risk
Short answer: yes. No product blocks RSV every time. The goal is to prevent the worst outcomes. Two tools now help protect babies:
- Maternal RSV vaccine (Abrysvo) given at 32–36 weeks of pregnancy to pass antibodies to the newborn.
- Nirsevimab, a single-dose long-acting antibody given to the baby before or during the first RSV season; some high-risk toddlers get a dose before their second season.
Early U.S. data show strong protection against RSV hospital stays with nirsevimab, and maternal vaccination lowers the chance that young infants end up in the hospital with RSV. That means a baby might still catch RSV, but the odds of severe illness drop a lot when protected. (See sources linked in the body.)
RSV Protection Options And What Each One Does
The table below gives a quick map of options, timing, and the outcome each one targets.
| Option | Who/When | What It Reduces |
|---|---|---|
| Maternal RSV Vaccine (Abrysvo) | Pregnant person at 32–36 weeks; protects baby from birth | RSV lower-respiratory disease and severe disease in first 6 months |
| Nirsevimab (Long-Acting Antibody) | Infants under 8 months, given once before or during first season | RSV hospital stays and medically attended lower-respiratory infections |
| Nirsevimab (Second Season Dose) | Age 8–19 months with high-risk conditions entering second season | Severe outcomes in higher-risk toddlers |
| Palivizumab | Monthly shots for select very high-risk infants where used | Severe RSV in narrow high-risk groups |
| Breastfeeding | Early months | General immune support; not a replacement for medical products |
| Hand Hygiene | Daily care and during sick contacts | Spread of RSV on hands, toys, and surfaces |
| Smoke-Free Home Air | All infants, all seasons | Lower airway irritation that can worsen RSV symptoms |
| Limiting Close Sick Contacts | During local RSV peaks | Exposure dose and chance of infection |
How These Protections Work
Maternal Vaccination: Antibodies Shared Before Birth
The maternal RSV vaccine is given during weeks 32–36. Antibodies cross the placenta and protect the newborn from day one. U.S. regulators authorized Abrysvo for this use, and public health agencies recommend it during the fall-winter window in most regions. Protection starts at birth and fades across the first months of life as maternal antibodies wane. Parents still use everyday prevention during this time. FDA approval details for Abrysvo lay out the timing window and indication.
Nirsevimab: Ready-Made Antibodies For The Baby
Nirsevimab isn’t a vaccine; it’s a long-acting antibody given as one shot to the infant. It supplies protection during the season when babies are most at risk. In early U.S. surveillance, nirsevimab cut RSV hospital stays by around 90% among young infants during their first season. That estimate came mid-season with limited supply, and protection can fade over months as antibodies clear, but the benefit against severe outcomes was clear. You can read the CDC’s study summary here: MMWR early effectiveness estimate.
Can Babies Get RSV After Vaccination? What To Expect
Yes, RSV can still break through, especially later in the season as antibodies fall. Most protected babies who do get infected have milder illness. In practice, that often means less labored breathing, fewer oxygen needs, shorter stays if admitted, and a lower chance of intensive care. That’s the headline benefit for families: fewer scary nights in the hospital.
Why Breakthroughs Happen
RSV Is Common And Spreads Easily
RSV moves through households, daycares, and clinics with ease. Touching the same toy or doorknob, then touching a face, is enough. Even with strong tools, perfect protection isn’t realistic because exposure can be frequent and intense.
Antibodies Fade With Time
Passive antibodies from maternal vaccination and nirsevimab slowly drop across weeks to months. Protection is highest in the early window and gradually softens later in the season.
Timing Gaps
Some babies are born outside the recommended window or miss a clinic visit during peak spread. Others get a dose after they were already infected earlier in the season. These real-life gaps explain part of what parents see.
How To Lower Your Baby’s RSV Risk Even More
Plan The Timing With Your Care Team
If you’re pregnant, ask about the maternal RSV shot during weeks 32–36 when that timing overlaps your region’s RSV season. If your baby is entering the first season, ask about nirsevimab before exposure ramps up. In many places, providers aim for early fall for both strategies. The American Academy of Pediatrics keeps a current overview of RSV prevention options for families and clinicians; see their RSV prevention page.
Limit Sick Contacts During Surges
When RSV is buzzing in your area, shorten high-exposure visits, favor outdoor meetups, and postpone close-contact playdates if someone is coughing or wheezing.
Wash Hands, Clean Shared Surfaces
Soap and water for 20 seconds or an alcohol-based rub makes a difference. Wipe down shared toys and high-touch spots in a regular rhythm.
Keep Indoor Air Smoke-Free
Smoke irritates airway lining. Babies with RSV breathe harder when airways are irritated. Protect the nursery, car, and caregiving spaces.
Symptoms To Watch And When To Call
Protected babies can still feel crummy with a cough and stuffy nose. The checklist below helps you track what’s typical and what needs care fast.
| Symptom | RSV In Babies | Usual Cold |
|---|---|---|
| Fever | Common, higher in first 2–3 days | Mild or none |
| Cough | Frequent; may sound wet | Mild to moderate |
| Breathing Effort | Fast breaths, belly pulling in, flaring nostrils | Normal work of breathing |
| Wheezing | Can occur, especially in younger infants | Uncommon |
| Feeding | Poor intake due to congestion | Slightly reduced |
| Color Changes | Pale or blue tinge around lips = urgent | Not expected |
| Course | Peaks day 3–5; slow ease after | Steady improvement by day 3 |
When To Seek Urgent Care
- Breathing faster than normal, belly pulling between ribs, grunting, or head bobbing.
- Blue or gray color around lips or face.
- Fewer wet diapers, dry mouth, or no tears when crying.
- Hard to wake, floppy, or not feeding at all.
- Fever in a baby under 3 months, or any fever that worries you.
What If The Baby Already Had RSV?
Re-infections happen. Later cases tend to be milder, but not always. If your baby qualifies for nirsevimab or lives with a heart, lung, or immune condition, ask whether they should still receive it for the remainder of the season or before the next one if eligible. Plans can change based on supply and local guidance.
How Protection Is Measured
Public health teams follow outcomes across seasons, hospitals, and clinics. For nirsevimab, early U.S. data during the 2023–24 season showed a large drop in RSV-related hospital stays among infants who received the shot. That estimate came from the CDC’s New Vaccine Surveillance Network using a test-negative design. Maternal vaccination also shows real-world reductions in infant RSV hospital stays in cohort data. Together, these tools are shifting the RSV season toward fewer severe cases in the youngest babies. Key references include the CDC’s early effectiveness report and the FDA’s approval summary for the maternal vaccine.
Putting It All Together For Your Family
Here’s a quick plan you can follow with your care team:
- During Pregnancy: Ask about the maternal RSV shot during weeks 32–36 if that window overlaps your local season.
- After Birth: If maternal vaccination wasn’t given, or if timing didn’t line up, ask about a nirsevimab dose before the first peak hits.
- High-Risk Toddlers: If entering a second season with high-risk conditions, confirm whether a nirsevimab dose is advised.
- Everyday Tactics: Hand cleaning, smoke-free indoor air, and smart sick-day choices lower exposure.
- Know The Red Flags: Use the symptom table and the urgent-care list above.
Can A Baby Get RSV If Vaccinated? Practical Takeaways
- Yes—breakthrough RSV can happen. Protection targets severe disease, not just infection.
- Protection is strongest early and eases over months as antibodies fall.
- Both strategies help: maternal vaccination for the newborn window; nirsevimab for infants through the season.
- Real-world data back the drop in hospital stays, which is what parents care about most.
How We Built This Guide
This piece draws on leading public sources and surveillance data. See the CDC’s early nirsevimab effectiveness report and the FDA’s authorization page for the maternal vaccine for timing and use indications. Wider policy summaries from the American Academy of Pediatrics and the World Health Organization align on using maternal vaccination and infant antibodies to protect babies in the first season.
Note: Product availability and local timing can shift by region and season. Your clinician can match the plan to your baby’s age, risks, and local RSV pattern.